Skip to main content
Clinical Trials/EUCTR2018-003939-30-NO
EUCTR2018-003939-30-NO
Active, not recruiting
Phase 1

Determination of analgesic equipotent doses of inhaled metoxyflurane vs. intravenous fentanyl using cold pressor test (CPT) in volunteers: A randomized, double blind, placebo-controlled crossover study. - metoxyflurane vs. fentanyl

Oslo University Hospital0 sites12 target enrollmentDecember 12, 2018

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Experimental pain model (cold pressor test – CPT) will be used to determinate equipotent doses of inhaled metoxyflurane vs. intravenous fentanyl.
Sponsor
Oslo University Hospital
Enrollment
12
Status
Active, not recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 12, 2018
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Oslo University Hospital

Eligibility Criteria

Inclusion Criteria

  • The volunteers should be in good health and not have any chronic illness.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 12
  • F.1\.3 Elderly (\>\=65 years) no
  • F.1\.3\.1 Number of subjects for this age range 0

Exclusion Criteria

  • No use of pain medication and complementary medicine the last 2 days before a session. Previous substance abuse, pregnancy and known allergies or serious side effects to opioids or metoxyflurane.

Outcomes

Primary Outcomes

Not specified

Similar Trials